KALA BIO, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
KALA BIO, INC. (KALA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of -$136.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-19
- KALA BIO, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was -$136.00K, a 106.07% decline year-over-year.
- KALA BIO, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was -$471.00K, a 120.39% decline year-over-year.
- KALA BIO, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $401.00K, a 80.85% decline year-over-year.
- KALA BIO, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $2.04M, a 0.39% increase year-over-year.
- KALA BIO, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $7.00M, a 16.62% decline from fiscal 2024.
- KALA BIO, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $8.39M, a 12.41% increase from fiscal 2023.
- KALA BIO, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $7.46M, a 7.26% increase from fiscal 2022.
- KALA BIO, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $6.96M, a 58.08% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$136.00K 10-Q · filed 2026-08-19 | -$607.00K 10-Q · filed 2026-08-19 | -$206.00K derived: sum of 3 quarters · filed 2026-08-19 | $1.84M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | -$471.00K 10-Q · filed 2026-05-15 | -$70.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.97M derived: sum of 3 quarters · filed 2026-05-15 | $4.21M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $2.44M derived: sum of 2 quarters · filed 2026-04-15 | $4.68M derived: sum of 3 quarters · filed 2026-08-19 | $7.00M 10-K · filed 2026-04-15 |
| 2025-09-30 | $2.04M 10-Q · filed 2025-11-19 | $4.28M derived: sum of 2 quarters · filed 2026-08-19 | $6.59M 10-Q · filed 2025-11-19 | $8.69M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $2.24M 10-Q · filed 2026-08-19 | $4.55M 10-Q · filed 2026-08-19 | $6.64M derived: sum of 3 quarters · filed 2026-08-19 | $8.68M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $2.31M 10-Q · filed 2026-05-15 | $4.40M derived: sum of 2 quarters · filed 2026-05-15 | $6.44M derived: sum of 3 quarters · filed 2026-05-15 | $8.32M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $4.13M derived: sum of 2 quarters · filed 2026-04-15 | $6.01M derived: sum of 3 quarters · filed 2026-04-15 | $8.39M 10-K · filed 2026-04-15 |
| 2024-09-30 | $2.04M 10-Q · filed 2025-11-19 | $3.92M derived: sum of 2 quarters · filed 2025-11-19 | $6.29M 10-Q · filed 2025-11-19 | $8.67M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $1.88M 10-Q · filed 2025-08-08 | $4.26M 10-Q · filed 2025-08-08 | $6.63M derived: sum of 3 quarters · filed 2025-08-08 | $9.04M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $2.38M 10-Q · filed 2025-05-14 | $4.75M derived: sum of 2 quarters · filed 2025-05-14 | $7.15M derived: sum of 3 quarters · filed 2025-05-14 | $8.52M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.78M derived: sum of 2 quarters · filed 2025-03-31 | $6.14M derived: sum of 3 quarters · filed 2025-03-31 | $7.46M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.40M 10-Q · filed 2024-11-12 | $3.77M derived: sum of 2 quarters · filed 2024-11-12 | $5.09M 10-Q · filed 2024-11-12 | $6.08M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.36M 10-Q · filed 2024-08-06 | $2.69M 10-Q · filed 2024-08-06 | $3.67M derived: sum of 3 quarters · filed 2024-08-06 | $5.05M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $1.32M 10-Q · filed 2024-05-14 | $2.31M derived: sum of 2 quarters · filed 2024-05-14 | $3.69M derived: sum of 3 quarters · filed 2024-05-14 | $5.53M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $988.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $2.36M derived: sum of 2 quarters · filed 2024-03-29 | $4.20M derived: sum of 3 quarters · filed 2024-03-29 | $6.96M 10-K · filed 2024-03-29 |
| 2022-09-30 | $1.37M 10-Q · filed 2023-11-13 | $3.21M derived: sum of 2 quarters · filed 2023-11-13 | $5.97M 10-Q · filed 2023-11-13 | $8.70M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.84M 10-Q · filed 2023-08-04 | $4.60M 10-Q · filed 2023-08-04 | $7.33M derived: sum of 3 quarters · filed 2023-08-04 | $11.42M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $2.76M 10-Q · filed 2023-05-09 | $5.49M derived: sum of 2 quarters · filed 2023-05-09 | $9.58M derived: sum of 3 quarters · filed 2023-05-09 | $14.47M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $6.82M derived: sum of 2 quarters · filed 2023-03-03 | $11.71M derived: sum of 3 quarters · filed 2023-03-03 | $16.60M 10-K · filed 2023-03-03 |
| 2021-09-30 | $4.09M 10-Q · filed 2022-11-08 | $8.98M derived: sum of 2 quarters · filed 2022-11-08 | $13.87M 10-Q · filed 2022-11-08 | $18.21M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $4.89M 10-Q · filed 2022-08-11 | $9.78M 10-Q · filed 2022-08-11 | $14.12M derived: sum of 3 quarters · filed 2022-08-11 | $18.39M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $4.89M 10-Q · filed 2022-05-16 | $9.23M derived: sum of 2 quarters · filed 2022-05-16 | $13.49M derived: sum of 3 quarters · filed 2022-05-16 | $16.27M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $8.61M derived: sum of 2 quarters · filed 2022-03-29 | $11.38M derived: sum of 3 quarters · filed 2022-03-29 | $13.97M 10-K · filed 2022-03-29 |
| 2020-09-30 | $4.27M 10-Q · filed 2021-11-15 | $7.04M derived: sum of 2 quarters · filed 2021-11-15 | $9.63M 10-Q · filed 2021-11-15 | $11.93M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $2.77M 10-Q · filed 2021-08-05 | $5.36M 10-Q · filed 2021-08-05 | $7.66M derived: sum of 3 quarters · filed 2021-08-05 | $10.14M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $2.58M 10-Q · filed 2021-05-05 | $4.88M derived: sum of 2 quarters · filed 2021-05-05 | $7.37M derived: sum of 3 quarters · filed 2021-05-05 | $9.89M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.79M derived: sum of 2 quarters · filed 2021-02-25 | $7.31M derived: sum of 3 quarters · filed 2021-02-25 | $10.05M 10-K · filed 2021-02-25 |
| 2019-09-30 | $2.49M 10-Q · filed 2020-11-05 | $5.01M derived: sum of 2 quarters · filed 2020-11-05 | $7.75M 10-Q · filed 2020-11-05 | $10.11M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $2.52M 10-Q · filed 2020-08-06 | $5.26M 10-Q · filed 2020-08-06 | $7.62M derived: sum of 3 quarters · filed 2020-08-06 | $9.95M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $2.74M 10-Q · filed 2020-05-07 | $5.10M derived: sum of 2 quarters · filed 2020-05-07 | $7.43M derived: sum of 3 quarters · filed 2020-05-07 | $9.72M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $4.69M derived: sum of 2 quarters · filed 2020-02-12 | $6.98M derived: sum of 3 quarters · filed 2020-02-12 | $8.84M 10-K · filed 2020-02-12 |
| 2018-09-30 | $2.33M 10-Q · filed 2019-11-07 | $4.62M derived: sum of 2 quarters · filed 2019-11-07 | $6.48M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $2.29M 10-Q · filed 2019-08-06 | $4.15M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $1.86M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $3.57M 10-K · filed 2019-03-12 | |||
| 2016-12-31 | $2.07M 10-K · filed 2018-04-02 | |||
| 2015-12-31 | $638.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |